Occlusion

Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of…

3 days ago

Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of…

3 days ago